Melrilimab (Anti-IL-1RL1 / ST2 / IL-33R)
Melrilimab (anti-IL-1RL1/ ST2 / IL-33R) is an anti-ST2 (IL-1RL) monoclonal antibody targeting the IL-33 receptor. Melrilimab has the potential to be used in asthma research. MW: 145.2 KD.
Trivial name | GSK 3772847; CNTO-7160 |
Catalog Number | A2962 |
CAS# | 2222865-46-3 |
Size | 1mg*5 |